clonidine has been researched along with ADDH in 190 studies
Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A pilot comparison of the safety and efficacy of methylphenidate (MPH) combined with clonidine, clonidine monotherapy, or MPH monotherapy in 6- to 16-year-old children diagnosed with attention deficit hyperactivity disorder (ADHD) and comorbid aggressive oppositional defiant disorder or conduct disorder was completed." | 9.09 | A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. ( Barkley, RA; Connor, DF; Davis, HT, 2000) |
| "8 years) with autistic disorder, diagnosed by DSM-III-R criteria, completed a placebo-controlled, double-blind crossover trial of clonidine." | 9.07 | Clonidine treatment of hyperactive and impulsive children with autistic disorder. ( Cook, EH; Fletcher, KE; Jaselskis, CA; Leventhal, BL, 1992) |
| "Atomoxetine and OROS methylphenidate were successfully used concomitantly in a 10-year-old boy suffering from attention-deficit/hyperactivity disorder (ADHD) with comorbid bipolar disorder and Tourette syndrome (TS)." | 7.73 | Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome. ( Benarroch, F; Gross-Tsur, V; Jaworowski, S, 2006) |
| "We concluded that the incidence of clonidine poisoning had increased over the specified period and that, based on our results, this was likely to be due to an increase in clonidine use in childhood behavioural disorders." | 7.70 | Clonidine poisoning--an emerging problem: epidemiology, clinical features, management and preventative strategies. ( Duncan, A; Erickson, SJ, 1998) |
| "Clonidine is an alpha-adrenergic agonist which may alleviate emerging symptoms in Tourette syndrome, an observation that has fueled speculation regarding involvement of stress-sensitive central noradrenergic systems in this disorder." | 7.69 | Predictors of clonidine response in Tourette syndrome: implications and inferences. ( Jackson, LA; Lichter, DG, 1996) |
| "Treatment of sleep disorders can be difficult in these children." | 6.73 | Use of clonidine in children with autism spectrum disorders. ( Gordon, E; Kang, N; Ming, X; Wagner, GC, 2008) |
| "There were more incidents of bradycardia in subjects treated with clonidine compared with those not treated with clonidine (17." | 5.13 | Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis. ( Bukstein, OG; Daviss, WB; Harris, P; McDERMOTT, MP; Palumbo, D; Patel, NC; Pelham, WE; Robb, AS; Sallee, FR, 2008) |
| "A pilot comparison of the safety and efficacy of methylphenidate (MPH) combined with clonidine, clonidine monotherapy, or MPH monotherapy in 6- to 16-year-old children diagnosed with attention deficit hyperactivity disorder (ADHD) and comorbid aggressive oppositional defiant disorder or conduct disorder was completed." | 5.09 | A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. ( Barkley, RA; Connor, DF; Davis, HT, 2000) |
| "8 years) with autistic disorder, diagnosed by DSM-III-R criteria, completed a placebo-controlled, double-blind crossover trial of clonidine." | 5.07 | Clonidine treatment of hyperactive and impulsive children with autistic disorder. ( Cook, EH; Fletcher, KE; Jaselskis, CA; Leventhal, BL, 1992) |
| " The study aimed to determine the risk of TBI in TS patients, the effects associated with concurrent psychiatric disorders (attention-deficit/hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD), or depressive disorder), and the effects of medication treatment (antipsychotics, antidepressants, or clonidine) on the risk of TBI." | 3.91 | Tourette's syndrome is associated with an increased risk of traumatic brain injury: A nationwide population-based cohort study. ( Chen, SF; Hsu, CY; Shen, YC; Su, YC; Wang, LY, 2019) |
| " The authors identified children with ≥1 clonidine prescription; the authors examined their ICD-9 diagnoses categorized as simple and complex attention deficit hyperactivity disorder (ADHD), non-ADHD mental health disorder, hypertension, or others." | 3.78 | Clonidine utilization trends for Medicaid children. ( Clark, SJ; Cohn, L; Kershaw, D; Rocchini, A; Yoon, EY, 2012) |
| "This paper reports on the use of clonidine for the treatment of severe sleep problems associated with behavioural difficulties in children with neurodevelopmental disabilities." | 3.73 | The use of clonidine for severe and intractable sleep problems in children with neurodevelopmental disorders--a case series. ( Ingrassia, A; Turk, J, 2005) |
| "Atomoxetine and OROS methylphenidate were successfully used concomitantly in a 10-year-old boy suffering from attention-deficit/hyperactivity disorder (ADHD) with comorbid bipolar disorder and Tourette syndrome (TS)." | 3.73 | Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome. ( Benarroch, F; Gross-Tsur, V; Jaworowski, S, 2006) |
| "We concluded that the incidence of clonidine poisoning had increased over the specified period and that, based on our results, this was likely to be due to an increase in clonidine use in childhood behavioural disorders." | 3.70 | Clonidine poisoning--an emerging problem: epidemiology, clinical features, management and preventative strategies. ( Duncan, A; Erickson, SJ, 1998) |
| "Clonidine is an alpha-adrenergic agonist which may alleviate emerging symptoms in Tourette syndrome, an observation that has fueled speculation regarding involvement of stress-sensitive central noradrenergic systems in this disorder." | 3.69 | Predictors of clonidine response in Tourette syndrome: implications and inferences. ( Jackson, LA; Lichter, DG, 1996) |
| "Growth hormone (GH) and beta-endorphin (beta-EP) responses to clonidine stimulation were examined in 18 male heroin addicts, 9 with and 9 without previous histories of attention deficit disorder with hyperactivity (ADD-H) and conduct disorder (CD)." | 3.69 | Alpha-2-adrenoceptor sensitivity in heroin addicts with and without previous attention deficit disorder/hyperactivity and conduct disorder. ( Avanzini, P; Brambilla, F; Caccavari, R; Delsignore, R; Fertonani-Affini, G; Fontanesi, B; Gerra, G; Maestri, D; Marcato, A; Perna, G, 1994) |
| "Growth hormone (GH) and 3-methoxy-4-hydroxyphenelethylene glycol (MHPG) response was measured hourly for 4 hours in 8 children with Attention Deficit Disorder with Hyperactivity (ADD+H) following an acute single-dose of clonidine." | 3.67 | Possible change in noradrenergic receptor sensitivity following methylphenidate treatment: growth hormone and MHPG response to clonidine challenge in children with attention deficit disorder and hyperactivity. ( Anderson, G; Clark, L; Cohen, DJ; Hunt, RD, 1984) |
| "Clonidine was effective in improving the hyperactivity and impulsivity symptoms in children with ADHD as compared to carbamazepine." | 2.74 | Randomised controlled study-efficacy of clonidine versus carbamazepine in children with ADHD. ( Mahadevan, S; Nair, V, 2009) |
| "Clonidine was well tolerated despite the frequency of sedation and did offer some benefit." | 2.73 | Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes. ( Bukstein, OG; Daviss, WB; McDERMOTT, MP; Palumbo, DR; Pelham, WE; Sallee, FR, 2008) |
| "Treatment of sleep disorders can be difficult in these children." | 2.73 | Use of clonidine in children with autism spectrum disorders. ( Gordon, E; Kang, N; Ming, X; Wagner, GC, 2008) |
| "Lofexidine was associated with insignificant decreases in blood pressure and pulse." | 2.71 | A placebo-controlled study of lofexidine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. ( Mair, A; Niederhofer, H; Staffen, W, 2003) |
| "All had comorbid mental retardation." | 2.70 | Double-blind, placebo-controlled trial of clonidine in hyperactive children with mental retardation. ( Agarwal, V; Kumar, S; Prasad, M; Sitholey, P, 2001) |
| " Transient sedation lasting 2 to 3 days occurred after initial administration or dosage increase; otherwise, clonidine was well tolerated." | 2.67 | Clonidine therapy for comorbid attention deficit hyperactivity disorder and conduct disorder: preliminary findings in a children's inpatient unit. ( Mandoki, MW; Schvehla, TJ; Sumner, GS, 1994) |
| " In one study, tics limited further dosage increases of methylphenidate." | 2.58 | Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders. ( Osland, ST; Pringsheim, T; Steeves, TD, 2018) |
| " Clonidine, melatonin, L-theanine, eszopiclone and guanfacine were well tolerated with mild to moderate adverse events; zolpidem was associated with neuropsychiatric adverse effects." | 2.55 | Safety, Tolerability and Efficacy of Drugs for Treating Behavioural Insomnia in Children with Attention-Deficit/Hyperactivity Disorder: A Systematic Review with Methodological Quality Assessment. ( Anand, S; Besag, FMC; Chan, EW; Cortese, S; Tong, H; Wong, ICK, 2017) |
| " Withdrawals due to all-cause, adverse effects and lack of efficacy were defined as primary outcomes evaluating the safety of such medications." | 2.55 | An Evaluation on the Efficacy and Safety of Treatments for Attention Deficit Hyperactivity Disorder in Children and Adolescents: a Comparison of Multiple Treatments. ( Gao, J; He, S; Li, Y; Wang, Q; Zhang, Y, 2017) |
| "Desipramine and placebo were similar on "all-cause treatment discontinuation" (RD -0." | 2.50 | Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents. ( Castells, X; Ehimare, UP; Otasowie, J; Smith, CH, 2014) |
| " While medications for ADHD are generally well-tolerated, there are common, although less severe, as well as rare but severe adverse events AEs during treatment with ADHD drugs." | 2.49 | Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. ( Banaschewski, T; Buitelaar, J; Coghill, D; Cortese, S; Danckaerts, M; Dittmann, RW; Graham, J; Holtmann, M; Sergeant, J; Taylor, E, 2013) |
| "Clonidine reduced insomnia; and melatonin also exhibited a positive response, with reduced sleep latency, higher total sleep time, and higher sleep efficiency." | 2.49 | To sleep or not to sleep: a systematic review of the literature of pharmacological treatments of insomnia in children and adolescents with attention-deficit/hyperactivity disorder. ( Barrett, JR; Giaroli, G; Tracy, DK, 2013) |
| "Clonidine XR was generally well tolerated as monotherapy and as adjunctive therapy with stimulant regimens in clinical trials in children and adolescents." | 2.47 | Clonidine extended-release: in attention-deficit hyperactivity disorder. ( Croxtall, JD, 2011) |
| " This review focuses on the tolerability, occurrence of adverse events, precautions required to prevent severe adverse events, and essential pharmacological interaction in the treatment of ADHD symptoms by non-stimulants." | 2.43 | The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder. ( Banaschewski, T; Heise, CA; Himpel, S; Rothenberger, A, 2005) |
| "Clonidine is a good option for managing core behavioral symptoms, especially hyperactivity and impulsivity." | 2.43 | Advances in alternative pharmacotherapy of ADHD. ( Pityaratstian, N, 2005) |
| " Methylphenidate and amphetamine-based stimulants are now available in longer-acting, once-daily and shorter-acting divided dosing schedules." | 2.42 | Pharmacological management of attention-deficit hyperactivity disorder. ( Reeves, G; Schweitzer, J, 2004) |
| " A recent group of placebo-controlled, double-blinded clinical trials have consistently shown that certain stimulants, particularly methylphenidate and dextroamphetamine, are effective, well tolerated, and safe when administered to treat ADHD in children with tics." | 2.42 | Tourette's syndrome: are stimulants safe? ( Kurlan, R, 2003) |
| "Tourette's disorder is a neuropsychiatric disorder characterised clinically by motor and vocal tics, which may be associated to conductual disorders such as obsessive-compulsive disorder (OCD) and attention-deficit hyperactivity disorder (ADHD)." | 2.41 | Pharmacological options for the treatment of Tourette's disorder. ( García-Ruiz, PJ; Jiménez-Jiménez, FJ, 2001) |
| "Clonidine has not been adequately examined but seems to have small or uncertain effects." | 2.40 | Antidepressants in the treatment of attention-deficit/hyperactivity disorder. ( Popper, CW, 1997) |
| "Patients with Korsakoff's disease, attention deficit disorder or schizophrenia may benefit from treatment with alpha 2-agents." | 2.39 | Pharmacological manipulations of the alpha 2-noradrenergic system. Effects on cognition. ( Coull, JT, 1994) |
| " Included are the drugs' putative mechanisms of action, pharmacology, toxicology, indications for their use, short-term and long-term actions, adverse effects, specific dosing regimens, therapeutic monitoring techniques, alternative medications, and drug interactions." | 2.38 | Pharmacologic treatment of attention deficit hyperactivity disorder. ( Greenhill, LL, 1992) |
| "Clonidine effectively alleviates tic symptoms, reduces attention deficit and hyperactivity/impulsivity in children with tic disorder co-morbid attention deficit hyperactivity disorder, and features a high safety profile." | 1.91 | Efficacy of clonidine in the treatment of children with tic disorder co-morbid with attention deficit hyperactivity disorder. ( Hu, B; Huang, XH; Wang, GL; Yuan, Y; Zeng, KD; Zhang, W, 2023) |
| "Clonidine was the most common medication to be used and was well tolerated." | 1.48 | Implications of comorbid ADHD in ASD interventions and outcome: Results from a naturalistic follow up study from south India. ( Chandrasekaran, V; Kandasamy, P; Kuppili, PP; Manohar, H; Rajkumar, RP, 2018) |
| " The IR forms, while themselves not FDA approved for ADHD, may, with dosage adjustment, be reasonable alternatives (with considerable cost savings)." | 1.43 | Treating ADHD in Prison: Focus on Alpha-2 Agonists (Clonidine and Guanfacine). ( Mattes, JA, 2016) |
| " Dexmethylphenidate XR is a stimulant treatment in a single isomer form, and has an efficacy and tolerability similar to two doses of immediate-release (IR) dexmethylphenidate when taken 4 hours apart, but is dosed at half of the usual d,l-methylphenidate dose." | 1.36 | Attention-deficit hyperactivity disorder: recent advances in paediatric pharmacotherapy. ( Kratochvil, CJ; May, DE, 2010) |
| "Clonidine users were characterized on the basis of demographics, comorbid conditions, medication use and provider types, and prescribing patterns before and after the index atomoxetine prescription assessed." | 1.33 | Decreased use of clonidine following treatment with atomoxetine in children with ADHD. ( Johnston, JA; Pohl, G; Sumner, CR; Van Brunt, DL; Ye, W, 2006) |
| " The in vitro release rate of the clonidine from KBD-TTS significantly correlated with the in vivo absorption rate (p<0." | 1.33 | In vitro and in vivo characterization of a newly developed clonidine transdermal patch for treatment of attention deficit hyperactivity disorder in children. ( Guo, HY; Ke, GM; Lu, WL; Wang, L; Xue, HY; Zhang, Q; Zhang, X, 2005) |
| "Pharmacological treatment of epilepsy is needed whenever epilepsy occurs." | 1.31 | [Medical treatment of fragile X syndrome]. ( Artigas-Pallarés, J; Brun-Gasca, C, 2001) |
| "Criteria of attention deficit disorder with hyperactivity are defined in DSM IV and CIM 10." | 1.31 | [Attention deficit disorder with hyperactivity in children: diagnosis and therapeutic management]. ( Vallée, L, 2000) |
| "Treatment with methylphenidate was more effective and better tolerated than treatment with clonidine." | 1.31 | [Functioning, comorbidity and treatment of 141 adults with attention deficit hyperactivity disorder (ADHD) at a psychiatric outpatient department]. ( Aeckerlin, LP; Buitelaar, JK; Kooij, JJ, 2001) |
| "While most of the clonidine exposures resulted in minimal toxic effects, serious toxic effects and death can occur." | 1.31 | Trends and toxic effects from pediatric clonidine exposures. ( Klein-Schwartz, W, 2002) |
| "Clonidine overdose is a potentially serious condition, often requiring intensive care management." | 1.30 | Clonidine overdose in childhood: implications of increased prescribing. ( Hanson, RM; Hutchins, P; Kappagoda, C; Schell, DN, 1998) |
| "Clonidine was helpful in ameliorating these behaviors." | 1.29 | Case study: behavioral symptoms of pediatric HIV-1 encephalopathy successfully treated with clonidine. ( Cebollero, AM; Ceseña, M; Lee, DO; Steingard, RJ, 1995) |
| "Because in many patients with Tourette's syndrome (TS) the ADHD symptoms are the major source of disability, alternative nonstimulant treatments are needed." | 1.29 | Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome. ( Biederman, J; Spencer, T; Steingard, R; Wilens, T, 1993) |
| "Clonidine treatment resulted in improvement in both the ADHD (39/54; 72%) and tic symptoms (18/24; 75%) groups." | 1.29 | Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders. ( Biederman, J; Gonzalez, A; Spencer, T; Steingard, R; Wilens, T, 1993) |
| " This article is a guide to its usage in children and includes discussion of its indications, contraindications, pre-treatment laboratory studies, dosing and drug interactions." | 1.29 | Clonidine: a practical guide for usage in children. ( Oesterheld, J; Tervo, R, 1996) |
| "Tourette syndrome is a neuropsychiatric disorder of motor and vocal tics, with associated symptoms of obsessive-compulsive behaviors and attention deficit disorder with hyperactivity." | 1.27 | [The treatment of children with Gilles de la Tourette's syndrome]. ( Minderaa, RB, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (7.37) | 18.7374 |
| 1990's | 58 (30.53) | 18.2507 |
| 2000's | 58 (30.53) | 29.6817 |
| 2010's | 52 (27.37) | 24.3611 |
| 2020's | 8 (4.21) | 2.80 |
| Authors | Studies |
|---|---|
| Newcorn, JH | 4 |
| Krone, B | 1 |
| Dittmann, RW | 2 |
| Pipe, A | 1 |
| Ravindran, N | 1 |
| Paric, A | 1 |
| Patterson, B | 1 |
| Van Ameringen, M | 1 |
| Ravindran, AV | 1 |
| Zammit, J | 3 |
| Ferrafiat, V | 3 |
| Bang Madsen, K | 1 |
| Robakis, TK | 1 |
| Liu, X | 1 |
| Momen, N | 1 |
| Larsson, H | 1 |
| Dreier, JW | 1 |
| Kildegaard, H | 1 |
| Groth, JB | 1 |
| Hove Thomsen, P | 1 |
| Munk-Olsen, T | 1 |
| Bergink, V | 1 |
| Zeng, KD | 1 |
| Wang, GL | 1 |
| Yuan, Y | 1 |
| Zhang, W | 1 |
| Huang, XH | 1 |
| Hu, B | 1 |
| Miller, J | 1 |
| Perera, B | 1 |
| Shankar, R | 1 |
| Cutler, AJ | 1 |
| Mattingly, GW | 2 |
| Jain, R | 4 |
| O'Neal, W | 1 |
| Cortese, S | 6 |
| Coghill, D | 4 |
| Anand, S | 1 |
| Tong, H | 1 |
| Besag, FMC | 1 |
| Chan, EW | 1 |
| Wong, ICK | 1 |
| Naguy, A | 3 |
| Danborg, PB | 1 |
| Simonsen, AL | 1 |
| Gøtzsche, PC | 1 |
| Manohar, H | 1 |
| Kuppili, PP | 1 |
| Kandasamy, P | 1 |
| Chandrasekaran, V | 1 |
| Rajkumar, RP | 1 |
| Osland, ST | 1 |
| Steeves, TD | 1 |
| Pringsheim, T | 2 |
| Adamo, N | 2 |
| Del Giovane, C | 2 |
| Mohr-Jensen, C | 2 |
| Hayes, AJ | 2 |
| Carucci, S | 2 |
| Atkinson, LZ | 2 |
| Tessari, L | 1 |
| Banaschewski, T | 4 |
| Hollis, C | 1 |
| Simonoff, E | 2 |
| Zuddas, A | 2 |
| Barbui, C | 2 |
| Purgato, M | 2 |
| Steinhausen, HC | 2 |
| Shokraneh, F | 2 |
| Xia, J | 2 |
| Cipriani, A | 2 |
| Elsori, D | 1 |
| Alamiri, B | 1 |
| Chen, SF | 1 |
| Su, YC | 1 |
| Wang, LY | 1 |
| Hsu, CY | 1 |
| Shen, YC | 1 |
| Sallee, F | 1 |
| Connor, DF | 5 |
| Beckmann, KM | 1 |
| Fernández-Jaén, A | 1 |
| Martín Fernández-Mayoralas, D | 1 |
| Fernández-Perrone, AL | 1 |
| Calleja-Pérez, B | 1 |
| Muñoz-Jareño, N | 1 |
| López-Arribas, S | 1 |
| Nguyen, M | 1 |
| Tharani, S | 1 |
| Rahmani, M | 1 |
| Shapiro, M | 1 |
| Barrett, JR | 1 |
| Tracy, DK | 1 |
| Giaroli, G | 1 |
| Efron, D | 1 |
| Lycett, K | 1 |
| Sciberras, E | 1 |
| Kawaura, K | 1 |
| Karasawa, J | 1 |
| Chaki, S | 1 |
| Hikichi, H | 1 |
| Otasowie, J | 1 |
| Castells, X | 1 |
| Ehimare, UP | 1 |
| Smith, CH | 1 |
| Wrenn, CC | 1 |
| Heitzer, AM | 1 |
| Roth, AK | 1 |
| Nawrocki, L | 1 |
| Valdovinos, MG | 1 |
| Sohn, M | 1 |
| Talbert, J | 1 |
| Moga, DC | 1 |
| Blumenschein, K | 1 |
| Chan, E | 1 |
| Fogler, JM | 1 |
| Hammerness, PG | 1 |
| Mattes, JA | 1 |
| Li, Y | 1 |
| Gao, J | 1 |
| He, S | 1 |
| Zhang, Y | 1 |
| Wang, Q | 1 |
| Katic, A | 1 |
| Anderson, RH | 1 |
| Bhatti, S | 1 |
| Ghanizadeh, A | 1 |
| Nair, V | 1 |
| Mahadevan, S | 1 |
| Scahill, L | 3 |
| Cannon, M | 1 |
| Pelham, WH | 1 |
| Sallee, FR | 5 |
| Palumbo, DR | 2 |
| Bukstein, O | 1 |
| Daviss, WB | 3 |
| May, DE | 1 |
| Kratochvil, CJ | 3 |
| Glazer, WM | 1 |
| Rowles, BM | 1 |
| Findling, RL | 3 |
| Segal, S | 2 |
| Kollins, SH | 3 |
| Khayrallah, M | 2 |
| Vorobyov, V | 1 |
| Schibaev, N | 1 |
| Kaptsov, V | 1 |
| Kovalev, G | 1 |
| Sengpiel, F | 1 |
| Dowben, JS | 1 |
| Grant, JS | 1 |
| Keltner, NL | 1 |
| Brams, M | 1 |
| Wigal, SB | 2 |
| Bidwell, LC | 1 |
| McClernon, FJ | 1 |
| Huang, YS | 1 |
| Tsai, MH | 1 |
| Keen, D | 1 |
| Hadijikoumi, I | 1 |
| Leggett, C | 1 |
| Hotham, E | 1 |
| Croxtall, JD | 2 |
| Roman, MW | 1 |
| Clement, HW | 1 |
| Schulz, E | 1 |
| Rickards, H | 1 |
| Cavanna, AE | 1 |
| Worrall, R | 1 |
| De Benedictis, L | 1 |
| Dumais, A | 1 |
| Landry, P | 1 |
| Saddichha, S | 1 |
| Vibha, P | 1 |
| Vishnuvardhan, G | 1 |
| Duong, S | 1 |
| Chung, K | 1 |
| Childress, AC | 1 |
| Yoon, EY | 1 |
| Cohn, L | 1 |
| Rocchini, A | 1 |
| Kershaw, D | 1 |
| Clark, SJ | 1 |
| Lachaine, J | 1 |
| Beauchemin, C | 1 |
| Sasane, R | 1 |
| Hodgkins, PS | 1 |
| Holtmann, M | 1 |
| Buitelaar, J | 1 |
| Danckaerts, M | 1 |
| Graham, J | 1 |
| Taylor, E | 2 |
| Sergeant, J | 2 |
| Kornfield, R | 1 |
| Watson, S | 1 |
| Higashi, AS | 1 |
| Conti, RM | 1 |
| Dusetzina, SB | 1 |
| Garfield, CF | 1 |
| Dorsey, ER | 1 |
| Huskamp, HA | 1 |
| Alexander, GC | 1 |
| Suchard, JR | 1 |
| Graeme, KA | 1 |
| Ramchandani, P | 3 |
| Joughin, C | 3 |
| Zwi, M | 3 |
| Artigas-Pallarés, J | 1 |
| Brun-Gasca, C | 1 |
| Levenson, D | 1 |
| Mao, ZM | 1 |
| Li, BM | 1 |
| Arnsten, AF | 4 |
| Niederhofer, H | 2 |
| Staffen, W | 1 |
| Mair, A | 1 |
| Kurlan, R | 1 |
| Kano, Y | 1 |
| Biederman, J | 7 |
| Spencer, T | 5 |
| Wilens, T | 5 |
| Reeves, G | 1 |
| Schweitzer, J | 1 |
| Symons, FJ | 1 |
| Thompson, A | 1 |
| Realmuto, G | 1 |
| McDougle, CJ | 1 |
| Ke, GM | 1 |
| Wang, L | 1 |
| Xue, HY | 1 |
| Lu, WL | 1 |
| Zhang, X | 1 |
| Zhang, Q | 1 |
| Guo, HY | 1 |
| Johnson, LA | 1 |
| Safranek, S | 1 |
| Friemoth, J | 1 |
| Ingrassia, A | 1 |
| Turk, J | 1 |
| Himpel, S | 1 |
| Heise, CA | 1 |
| Rothenberger, A | 1 |
| Lake, M | 1 |
| Pliszka, SR | 1 |
| Walkup, JT | 2 |
| Shah, M | 1 |
| Cork, C | 1 |
| Chowdhury, U | 1 |
| Wolraich, ML | 1 |
| Wibbelsman, CJ | 1 |
| Brown, TE | 1 |
| Evans, SW | 1 |
| Gotlieb, EM | 1 |
| Knight, JR | 1 |
| Ross, EC | 1 |
| Shubiner, HH | 1 |
| Wender, EH | 1 |
| Pritchard, D | 2 |
| Ambalavanan, G | 1 |
| Holten, KB | 1 |
| McDonald, CA | 1 |
| Guttinger, R | 1 |
| Joyce, D | 1 |
| Mendhekar, DN | 1 |
| Faraone, SV | 1 |
| Doyle, AE | 1 |
| Spencer, TJ | 3 |
| Wilens, TE | 5 |
| Weiss, MD | 1 |
| Safren, SA | 1 |
| Culpepper, L | 1 |
| Rains, A | 1 |
| Hamrin, V | 1 |
| Lecendreux, M | 1 |
| Mouren, MC | 1 |
| Konofal, E | 1 |
| Pityaratstian, N | 1 |
| Varley, C | 1 |
| Cummins, TK | 1 |
| Martin, A | 1 |
| Jaworowski, S | 1 |
| Benarroch, F | 1 |
| Gross-Tsur, V | 1 |
| Johnston, JA | 1 |
| Ye, W | 1 |
| Van Brunt, DL | 1 |
| Pohl, G | 1 |
| Sumner, CR | 1 |
| Prasad, S | 1 |
| Harpin, V | 1 |
| Poole, L | 1 |
| Zeitlin, H | 1 |
| Jamdar, S | 1 |
| Puvanendran, K | 1 |
| Kotcher, L | 1 |
| Wieland, N | 1 |
| Coffey, B | 1 |
| Stella, MJ | 1 |
| Bailey, AG | 1 |
| Patel, NC | 2 |
| Robb, AS | 1 |
| McDERMOTT, MP | 2 |
| Bukstein, OG | 2 |
| Pelham, WE | 2 |
| Palumbo, D | 1 |
| Harris, P | 1 |
| Feron, FJ | 1 |
| Hendriksen, JG | 1 |
| Nicolai, J | 1 |
| Vles, JS | 1 |
| Ming, X | 1 |
| Gordon, E | 1 |
| Kang, N | 1 |
| Wagner, GC | 1 |
| Sears, J | 1 |
| Hunt, RD | 8 |
| Cohen, DJ | 10 |
| Shaywitz, SE | 2 |
| Shaywitz, BA | 3 |
| Leckman, JF | 4 |
| Anderson, G | 1 |
| Clark, L | 1 |
| Bruun, RD | 1 |
| Gertner, JM | 1 |
| Ort, S | 2 |
| Harcherik, DF | 1 |
| Wolf, A | 1 |
| Loomis, R | 1 |
| Kwasman, A | 1 |
| Tinsley, BJ | 1 |
| Lepper, HS | 1 |
| Singer, HS | 2 |
| Brown, J | 1 |
| Quaskey, S | 1 |
| Rosenberg, LA | 1 |
| Mellits, ED | 1 |
| Denckla, MB | 1 |
| Wozniak, J | 1 |
| Connor, D | 1 |
| Scahill, LD | 1 |
| Riddle, MA | 2 |
| Ceseña, M | 1 |
| Lee, DO | 1 |
| Cebollero, AM | 1 |
| Steingard, RJ | 1 |
| Gerra, G | 1 |
| Caccavari, R | 1 |
| Fontanesi, B | 1 |
| Delsignore, R | 1 |
| Fertonani-Affini, G | 1 |
| Marcato, A | 1 |
| Maestri, D | 1 |
| Avanzini, P | 1 |
| Perna, G | 1 |
| Brambilla, F | 1 |
| Coull, JT | 1 |
| Horacek, HJ | 1 |
| Schvehla, TJ | 1 |
| Mandoki, MW | 1 |
| Sumner, GS | 1 |
| Culbert, TP | 1 |
| Banez, GA | 1 |
| Reiff, MI | 1 |
| Fargason, RE | 1 |
| Ford, CV | 1 |
| Chapman, NA | 1 |
| Rubinstein, S | 1 |
| Silver, LB | 1 |
| Licamele, WL | 1 |
| Gunning, WB | 2 |
| Hoehn, R | 1 |
| Stephens, KJ | 1 |
| Riley, W | 1 |
| Osten, C | 1 |
| Steingard, R | 3 |
| Geist, D | 1 |
| Gonzalez, A | 1 |
| Steere, JC | 1 |
| St Dennis, C | 1 |
| Synoground, G | 1 |
| Ryan, MG | 1 |
| Oesterheld, J | 1 |
| Tervo, R | 1 |
| Pearson, CC | 1 |
| Lichter, DG | 1 |
| Jackson, LA | 1 |
| Weaver, A | 1 |
| Eppright, TD | 1 |
| Stern, BL | 1 |
| Reid, J | 1 |
| Horwitz, E | 1 |
| Kooij, JJ | 2 |
| Goekoop, JG | 1 |
| Prince, JB | 1 |
| Wozniak, JR | 1 |
| Cantwell, DP | 1 |
| Swanson, J | 1 |
| Hagerman, R | 1 |
| Popper, CW | 1 |
| Peterson, BS | 1 |
| Erickson, SJ | 1 |
| Duncan, A | 1 |
| Ryan, ND | 1 |
| Doepfner, M | 1 |
| Gunning, B | 2 |
| Overmeyer, S | 1 |
| Möbius, HJ | 1 |
| Eisert, HG | 1 |
| Broderick-Cantwell, JJ | 1 |
| Levy, F | 1 |
| Kappagoda, C | 1 |
| Schell, DN | 1 |
| Hanson, RM | 1 |
| Hutchins, P | 1 |
| van der Meere, J | 1 |
| Stemerdink, N | 1 |
| Swanson, JM | 2 |
| Cantwell, D | 1 |
| Weller, EB | 1 |
| Rowan, A | 1 |
| Elia, J | 1 |
| Weller, RA | 1 |
| King, VL | 1 |
| Brooner, RK | 1 |
| Kidorf, MS | 1 |
| Stoller, KB | 1 |
| Mirsky, AF | 1 |
| Kofoed, L | 1 |
| Tadepalli, G | 1 |
| Oesterheld, JR | 1 |
| Awadallah, S | 1 |
| Shapiro, R | 1 |
| Dech, B | 1 |
| Fletcher, KE | 2 |
| Barkley, RA | 1 |
| Davis, HT | 1 |
| Kalb, C | 1 |
| Vallée, L | 1 |
| Agarwal, V | 1 |
| Sitholey, P | 1 |
| Kumar, S | 1 |
| Prasad, M | 1 |
| Romano, MJ | 1 |
| Dinh, A | 1 |
| Aeckerlin, LP | 1 |
| Buitelaar, JK | 2 |
| Gianarris, WJ | 1 |
| Golden, CJ | 1 |
| Greene, L | 1 |
| Jiménez-Jiménez, FJ | 1 |
| García-Ruiz, PJ | 1 |
| Klein-Schwartz, W | 1 |
| Sawyer, MG | 1 |
| Rey, JM | 1 |
| Graetz, BW | 1 |
| Clark, JJ | 1 |
| Baghurst, PA | 1 |
| Greenhill, LL | 1 |
| Jaselskis, CA | 1 |
| Cook, EH | 1 |
| Leventhal, BL | 1 |
| Vink, HJ | 1 |
| Althaus, M | 1 |
| Goorhuis-Brouwer, SM | 1 |
| Minderaa, RB | 4 |
| Hart-Santora, D | 1 |
| Hart, LL | 1 |
| van der Gaag, RJ | 1 |
| Polák, L | 1 |
| Molcan, J | 1 |
| Comings, DE | 1 |
| Comings, BG | 1 |
| Tacket, T | 1 |
| Li, SZ | 1 |
| Caruso, KA | 1 |
| Anderson, GM | 1 |
| Kremenitzer, M | 1 |
| Caine, ED | 1 |
| McBride, MC | 1 |
| Chiverton, P | 1 |
| Bamford, KA | 1 |
| Rediess, S | 1 |
| Shiao, J | 1 |
| Jensen, JB | 1 |
| Garfinkel, BD | 1 |
| Huisjes, HJ | 1 |
| Hadders-Algra, M | 1 |
| Touwen, BC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Observational Study Investigating the Experience of Patients Undergoing Active Insomnia Clinical Trials[NCT05978271] | 500 participants (Anticipated) | Observational | 2024-08-31 | Not yet recruiting | |||
| The Effects of Methylphenidate (MPH) and Non-invasive Brain Stimulation (tDCS) on Inhibitory Control Children With Attention-Deficit/Hyperactivity Disorder (ADHD)[NCT04964427] | 26 participants (Actual) | Interventional | 2021-02-08 | Completed | |||
| Open Label Study for the Use of Transcranial Ultrasound Treatment of Attention Deficit Hyperactive Disorder[NCT04497363] | 100 participants (Anticipated) | Interventional | 2020-07-01 | Enrolling by invitation | |||
| Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) Treatment (CAT)[NCT00031395] | Phase 3 | 122 participants (Actual) | Interventional | 1999-09-30 | Completed | ||
| A Phase III, Dose-Response Evaluation of the Efficacy and Safety of CLONICEL® (Clonidine HCl Sustained Release) vs. Placebo in the Treatment of Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)[NCT00556959] | Phase 3 | 236 participants (Actual) | Interventional | 2007-10-31 | Completed | ||
| Efficacy of Pharmacologic Management of ADHD in Children and Youth With Autism Spectrum Disorder[NCT05916339] | Phase 4 | 500 participants (Anticipated) | Interventional | 2023-10-01 | Not yet recruiting | ||
| Therapeutic Use of Repetitive Transcranial Magnetic Stimulation (rTMS) in Pediatric Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Cohorts (ADHD): a Randomized, Sham-controlled Study.[NCT06069323] | 80 participants (Anticipated) | Interventional | 2023-06-01 | Recruiting | |||
| [NCT00004325] | 200 participants | Observational | 1988-12-31 | Completed | |||
| A Single-blind, Randomised, Sham Controlled, Phase IIa Exploratory Clinical Trial, to Examine the Safety and Efficacy of BGX-3006 (tPCS) on Paediatric ADHD Participants.[NCT02323633] | Phase 2 | 48 participants (Anticipated) | Interventional | 2015-01-31 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
71 reviews available for clonidine and ADDH
| Article | Year |
|---|---|
Nonstimulant Treatments for ADHD.
Topics: Adrenergic alpha-2 Receptor Agonists; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyp | 2022 |
Treatments for child and adolescent attention deficit hyperactivity disorder in low and middle-income countries: A narrative review.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervou | 2022 |
Clinical guidance on pharmacotherapy for the treatment of attention-deficit hyperactivity disorder (ADHD) for people with intellectual disability.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidi | 2020 |
Current and future nonstimulants in the treatment of pediatric ADHD: monoamine reuptake inhibitors, receptor modulators, and multimodal agents.
Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central | 2022 |
A Practical, Evidence-informed Approach to Managing Stimulant-Refractory Attention Deficit Hyperactivity Disorder (ADHD).
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Atten | 2021 |
Safety, Tolerability and Efficacy of Drugs for Treating Behavioural Insomnia in Children with Attention-Deficit/Hyperactivity Disorder: A Systematic Review with Methodological Quality Assessment.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Eszopiclone; Glutamates; Guanfacine | 2017 |
Impaired reproduction after exposure to ADHD drugs: Systematic review of animal studies.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Clonidine; Female; Male; Methylphenidate; Re | 2017 |
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervou | 2018 |
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Attention Deficit Disorder with Hyperactivi | 2018 |
A review of the rationale and clinical utilization of α2-adrenoceptor agonists for the treatment of attention-deficit/hyperactivity and related disorders.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Attention Deficit Disorder with Hyperactivity; Clonid | 2013 |
[Autism and attention deficit hyperactivity disorder: pharmacological intervention].
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivi | 2013 |
A review of the use of clonidine as a sleep aid in the child and adolescent population.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Chi | 2014 |
To sleep or not to sleep: a systematic review of the literature of pharmacological treatments of insomnia in children and adolescents with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Glutamates; Humans; Pyr | 2013 |
Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Central | 2014 |
Clonidine Use in Psychiatry: Panacea or Panache.
Topics: Animals; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Clonidine; Humans; Men | 2016 |
Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Amphetamines; Atomoxetine Hydrochloride; Attention | 2016 |
An Evaluation on the Efficacy and Safety of Treatments for Attention Deficit Hyperactivity Disorder in Children and Adolescents: a Comparison of Multiple Treatments.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidi | 2017 |
Current and Investigational Medication Delivery Systems for Treating Attention-Deficit/Hyperactivity Disorder.
Topics: Adrenergic Agents; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperact | 2016 |
Optimizing outcomes in ADHD treatment: from clinical targets to novel delivery systems.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Anxiety Disorders; Atomoxetine H | 2016 |
Alpha-2 adrenergic agonists in children with inattention, hyperactivity and impulsiveness.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Child; Child Development D | 2009 |
The role of alpha2-adrenergic agonists in attention-deficit/hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervous System Sti | 2010 |
Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders.
Topics: Adolescent; Amphetamines; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorde | 2010 |
Another extended-release α2-agonist for ADHD.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Attention Deficit Disorder with Hyperactivity; Child; | 2011 |
Cognitive enhancers for the treatment of ADHD.
Topics: Adult; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; | 2011 |
Long-term outcomes with medications for attention-deficit hyperactivity disorder: current status of knowledge.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Atten | 2011 |
ADHD in children and adolescents.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit and Disruptive Behavior Disorders; Attentio | 2011 |
Clonidine extended-release: in attention-deficit hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Clonidine; Delayed-Action Preparations; Humans | 2011 |
New additions to the psychopharmacopia: extended release formulations.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Comparative Effectiveness Re | 2011 |
[α2-Adrenergic agonists, and drugs for ADHD].
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Chi | 2011 |
Metabolic, toxicological, and safety considerations for drugs used to treat ADHD.
Topics: Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nerv | 2012 |
Revisiting clonidine: an innovative add-on option for attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adrenergic alpha-Agonists; Amphetamine; Attention Deficit Disorder with Hyperactivity; B | 2012 |
Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents.
Topics: Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Blood Pressure | 2013 |
Attention deficit hyperactivity disorder in children.
Topics: Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; | 2002 |
[Roles of alpha-2 adrenoceptor in prefrontal cortical cognitive functions].
Topics: Adrenergic alpha-Agonists; Animals; Attention Deficit Disorder with Hyperactivity; Clonidine; Cognit | 1999 |
Attention deficit hyperactivity disorder in children.
Topics: Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; | 2002 |
Tourette's syndrome: are stimulants safe?
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Clinical | 2003 |
Attention deficit hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Combined Modality Therapy; Dextroam | 2003 |
[Chronic tic disorders--chronic mortor or vocal tic disorders and de la Tourette's syndrome].
Topics: Adolescent; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous Sy | 2003 |
Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Antidepressiv | 2004 |
Pharmacological management of attention-deficit hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Amphetamines; Antidepressive Agents; Atomoxetine Hydrochloride; Attention | 2004 |
Clinical inquiries. What is the most effective treatment for ADHD in children?
Topics: Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; | 2005 |
The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Adult; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Atten | 2005 |
Pharmacological management of treatment-induced insomnia in ADHD.
Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimula | 2005 |
ADHD: assessment and intervention.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior Diso | 2005 |
Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications.
Topics: Adolescent; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hypera | 2005 |
Attention deficit hyperactivity disorder in children.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Combined | 2005 |
Advances in alternative pharmacotherapy of ADHD.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperac | 2005 |
Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Defici | 2006 |
Attention deficit hyperactivity disorder in children.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Combined | 2006 |
alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Clonidine; Controlled Clin | 2007 |
Recent advances in Gilles de la Tourette syndrome: implications for clinical practice and future research.
Topics: Adolescent; Age Factors; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Compulsive | 1983 |
Disruptive behavior, hyperactivity, and learning disabilities in children with Tourette's syndrome.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Child; | 1995 |
Pharmacological manipulations of the alpha 2-noradrenergic system. Effects on cognition.
Topics: Aging; Alcohol Amnestic Disorder; Animals; Attention Deficit Disorder with Hyperactivity; Brain; Clo | 1994 |
Tic disorders.
Topics: Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Child; Child | 1993 |
[Attention deficit disorder with hyperactivity].
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Child; Child, Pr | 1994 |
Clinical patterns of ADHD: a treatment model based on brain functioning.
Topics: Arousal; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior Disorders; Child, Pres | 1994 |
The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Animals; Attention Deficit Disorder with Hyperactivity; Clonidine; Cognit | 1996 |
Clonidine.
Topics: Adolescent; Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Child; Clonidi | 1995 |
Self-induced overdose of ADHD medication.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; | 1996 |
[Attention deficit disorders with hyperactivity in adulthood; implications for diagnosis and treatment].
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Attention Deficit Disorder with Hyperactivity; Child; | 1996 |
Antidepressants in the treatment of attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents; Antidepressive Agents, Tricyclic; Attention D | 1997 |
The treatment of Tourette's syndrome: multimodal, developmental intervention.
Topics: Adaptation, Psychological; Adolescent; Adrenergic Agonists; Adult; Age Factors; Antidepressive Agent | 1998 |
Psychoneuroendocrinology of children and adolescents.
Topics: Adolescent; Adolescent Behavior; Attention Deficit Disorder with Hyperactivity; Child; Child Behavio | 1998 |
Aggressive behavior in patients with attention-deficit/hyperactivity disorder, conduct disorder, and pervasive developmental disorders.
Topics: Adolescent; Aggression; Attention Deficit Disorder with Hyperactivity; Carbamazepine; Child; Child D | 1999 |
A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder.
Topics: Adolescent; Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Child; Child B | 1999 |
The Conners' Parent Rating Scales: a critical review of the literature.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervous System Sti | 2001 |
Pharmacological options for the treatment of Tourette's disorder.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Botulinum | 2001 |
Pharmacologic treatment of attention deficit hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Child, Pres | 1992 |
Pharmacotherapy of Tourette's syndrome and associated disorders.
Topics: Attention Deficit Disorder with Hyperactivity; Clonidine; Female; Haloperidol; Humans; Male; Mental | 1992 |
Clonidine in attention deficit hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Child; Child, Preschool; Clonidine; | 1992 |
[Children with attention deficit disorders with hyperactivity; the role of drugs in treatment].
Topics: Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Child; Child, Presc | 1991 |
21 trials available for clonidine and ADDH
| Article | Year |
|---|---|
Use of sleep medication in children with ADHD.
Topics: Adolescent; Anxiety Disorders; Attention Deficit and Disruptive Behavior Disorders; Attention Defici | 2014 |
Randomised controlled study-efficacy of clonidine versus carbamazepine in children with ADHD.
Topics: Adrenergic alpha-Agonists; Analgesics, Non-Narcotic; Attention Deficit Disorder with Hyperactivity; | 2009 |
Effects of clonidine and methylphenidate on family quality of life in attention-deficit/hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervous System Sti | 2009 |
Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Chi | 2011 |
Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Chi | 2011 |
Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Chi | 2011 |
Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Chi | 2011 |
Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD.
Topics: Adolescent; Adolescent Behavior; Adrenergic alpha-2 Receptor Agonists; Amphetamine; Attention Defici | 2011 |
A placebo-controlled study of lofexidine in the treatment of children with tic disorders and attention deficit hyperactivity disorder.
Topics: Adolescent; Adrenergic Agonists; Analysis of Variance; Attention Deficit Disorder with Hyperactivity | 2003 |
A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD).
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with | 2007 |
Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Bradycardia; Central Nervo | 2008 |
Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervous System Sti | 2008 |
Use of clonidine in children with autism spectrum disorders.
Topics: Adolescent; Adrenergic alpha-Agonists; Aggression; Attention Deficit Disorder with Hyperactivity; At | 2008 |
The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine.
Topics: Adolescent; Analysis of Variance; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; D | 1995 |
Clonidine therapy for comorbid attention deficit hyperactivity disorder and conduct disorder: preliminary findings in a children's inpatient unit.
Topics: Attention Deficit Disorder with Hyperactivity; Blood Pressure; Child; Child Behavior Disorders; Chil | 1994 |
The effect of methylphenidate and clonidine on response inhibition and state regulation in children with ADHD.
Topics: Arousal; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants | 1999 |
A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder.
Topics: Adolescent; Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Child; Child B | 1999 |
A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder.
Topics: Adolescent; Adrenergic alpha-Agonists; Aggression; Attention Deficit Disorder with Hyperactivity; Ce | 2000 |
Double-blind, placebo-controlled trial of clonidine in hyperactive children with mental retardation.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Comorbidity; Dose-Respo | 2001 |
Treatment of ADHD in children with tics: a randomized controlled trial.
Topics: Adolescent; Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervou | 2002 |
Clonidine treatment of hyperactive and impulsive children with autistic disorder.
Topics: Ambulatory Care; Attention Deficit Disorder with Hyperactivity; Attitude to Health; Autistic Disorde | 1992 |
Clonidine and stuttering.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Female; Humans; Male; S | 1992 |
The therapeutic effect of clonidine in attention deficit disorder with hyperactivity: a comparison with placebo and methylphenidate.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clinical Trials as Topic; Clonidine; Double-Bl | 1986 |
Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Clinical Trials as Topic; Clonidin | 1985 |
99 other studies available for clonidine and ADDH
| Article | Year |
|---|---|
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
Interest of clonidine for seven inpatient youths with intellectual disability and other severe neurodevelopmental disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Clonidine; Huma | 2023 |
In utero exposure to ADHD medication and long-term offspring outcomes.
Topics: Adult; Amphetamines; Attention Deficit Disorder with Hyperactivity; Child, Preschool; Clonidine; Coh | 2023 |
Efficacy of clonidine in the treatment of children with tic disorder co-morbid with attention deficit hyperactivity disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; | 2023 |
Pharmacotherapy of Attention Deficit Hyperactivity Disorder Symptom Profile in ASD.
Topics: Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Autism Spect | 2017 |
Implications of comorbid ADHD in ASD interventions and outcome: Results from a naturalistic follow up study from south India.
Topics: Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Autism Spectrum | 2018 |
Methylphenidate-Induced Nocturnal Bruxism Alleviated by Adjunctive Clonidine.
Topics: Analgesics; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; | 2019 |
Tourette's syndrome is associated with an increased risk of traumatic brain injury: A nationwide population-based cohort study.
Topics: Adolescent; Adult; Antidepressive Agents; Antipsychotic Agents; Attention Deficit Disorder with Hype | 2019 |
Conflicting information from TGA versus FDA may undermine compliance with use of medication.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Age Factors; Attention Deficit Disorder with Hyper | 2013 |
Stimulation of postsynapse adrenergic α2A receptor improves attention/cognition performance in an animal model of attention deficit hyperactivity disorder.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Attention; Attention Defic | 2014 |
Effects of clonidine and methylphenidate on motor activity in Fmr1 knockout mice.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Attention Deficit Disorder with Hyperactivity; Centra | 2015 |
A cost-effectiveness analysis of off-label atypical antipsychotic treatment in children and adolescents with ADHD who have failed stimulant therapy.
Topics: Adolescent; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperac | 2016 |
Treating ADHD in Prison: Focus on Alpha-2 Agonists (Clonidine and Guanfacine).
Topics: Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Clonidine; Guan | 2016 |
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Attention Deficit Disorder with Hyperactivi | 2017 |
Insomnia, night terror, and depression related to clonidine in attention-deficit/hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervous System Sti | 2008 |
Attention-deficit hyperactivity disorder: recent advances in paediatric pharmacotherapy.
Topics: Administration, Oral; Adolescent; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperac | 2010 |
In the pipeline: non-stimulant ADHD meds.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Clonidine; Guanfacine; Hum | 2010 |
Cortical and hippocampal EEG effects of neurotransmitter agonists in spontaneously hypertensive vs. kainate-treated rats.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Baclofen; Clonidine; Disease Models, Animal; | 2011 |
Clonidine: diverse use in pharmacologic management.
Topics: Adolescent; Adult; Asperger Syndrome; Attention Deficit Disorder with Hyperactivity; Autistic Disord | 2011 |
Treatment experiences of children and adolescents with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Adolescent Behavior; Attention Deficit Disorder with Hyperactivity; Australia; Central N | 2011 |
Treatment practices in Tourette syndrome: the European perspective.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride | 2012 |
Successful treatment of severe disruptive disorder featuring symptoms of the Klüver-Bucy Syndrome following a massive right temporal-parietal hemorrhage.
Topics: Adrenergic alpha-Agonists; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Di | 2013 |
Clonidine extended-release in attention-deficit hyperactivity disorder: profile report.
Topics: Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Clonidine; Dela | 2012 |
Sapophagia (compulsive soap eating) and attention-deficit/hyperactivity disorder in a child responsive to clonidine.
Topics: Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Child; Clonidin | 2012 |
Clonidine utilization trends for Medicaid children.
Topics: Adolescent; Antihypertensive Agents; Attention Deficit Disorder with Hyperactivity; Child; Clonidine | 2012 |
Treatment patterns, adherence, and persistence in ADHD: a Canadian perspective.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Analysis of Variance | 2012 |
Psychopharmacology for the clinician: management of comorbid Tourette syndrome and attention-deficit/hyperactivity disorder: are psychostimulants an option?
Topics: Adrenergic alpha-2 Receptor Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervous | 2012 |
Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Amphetamines; Atomox | 2013 |
Pediatric clonidine poisoning as a result of pharmacy compounding error.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Drug Com | 2002 |
[Medical treatment of fragile X syndrome].
Topics: Adrenergic alpha-Agonists; Anticonvulsants; Antipsychotic Agents; Attention Deficit and Disruptive B | 2001 |
Ritalin is okay for kids with both ADHD and Tourette's syndrome, study says.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clinical Tr | 2002 |
Clonidine for self-injurious behavior.
Topics: Administration, Oral; Adolescent; Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperac | 2004 |
Methylphenidate an effective treatment for ADHD?
Topics: Adrenergic alpha-Agonists; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Auti | 2004 |
In vitro and in vivo characterization of a newly developed clonidine transdermal patch for treatment of attention deficit hyperactivity disorder in children.
Topics: Administration, Cutaneous; Animals; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; | 2005 |
The use of clonidine for severe and intractable sleep problems in children with neurodevelopmental disorders--a case series.
Topics: Adolescent; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Brain; Child; Cloni | 2005 |
How should we evaluate and treat ADHD in children and adolescents?
Topics: Adolescent; Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Behavior Thera | 2005 |
Case report: clonidine withdrawal after atypically high-dose maintenance treatment.
Topics: Adolescent; Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Clonidine; Hum | 2005 |
Clonidine-induced gynecomastia and hyperprolactinemia in a 6-year-old child.
Topics: Age Factors; Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Comor | 2005 |
New developments in the treatment of ADHD.
Topics: Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperac | 2006 |
Nonstimulant medications for the treatment of ADHD.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention De | 2006 |
ADHD and insomnia.
Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimula | 2006 |
Less is more: inpatient management of a child with complex pharmacotherapy.
Topics: Aggression; Amphetamines; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Depressio | 2006 |
Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivi | 2006 |
Decreased use of clonidine following treatment with atomoxetine in children with ADHD.
Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Atte | 2006 |
Trichotillomania and co-morbid psychiatric disorders in a 10-year-old boy.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Comorbidity; Drug Therapy, Combinat | 2007 |
Intranasal clonidine as a premedicant: three cases with unique indications.
Topics: Administration, Intranasal; Adrenergic alpha-Agonists; Asthma; Attention Deficit Disorder with Hyper | 2008 |
New-onset seizures: a possible association with clonidine?
Topics: Adrenergic alpha-Agonists; Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Cerebral | 2008 |
Development of tics in a thirteen-year-old male following atomoxetine use.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Anticonvulsants; Atomoxetine Hydrochloride; Attention Defi | 2008 |
Strategies for study of the neurochemistry of attention deficit disorder in children.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Dopamine beta-Hydroxylase; Growth H | 1982 |
Possible change in noradrenergic receptor sensitivity following methylphenidate treatment: growth hormone and MHPG response to clonidine challenge in children with attention deficit disorder and hyperactivity.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior; Clonidine; Drug In | 1984 |
Gilles de la Tourette's syndrome. An overview of clinical experience.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Clonidine; Compu | 1984 |
Growth hormone response to clonidine in children ages 4-17: Tourette's syndrome vs. children with short stature.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Body Height; Child; Child, Preschool; Clo | 1984 |
Animal models of neuropsychiatric disorders and their relevance for Tourette syndrome.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Clonidine; Disease Models, Animal; Dopamine; | 1982 |
Pediatricians' knowledge and attitudes concerning diagnosis and treatment of attention deficit and hyperactivity disorders. A national survey approach.
Topics: Adult; Aged; Amphetamines; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperac | 1995 |
Combined pharmacotherapy: an emerging trend in pediatric psychopharmacology.
Topics: Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Child Psychiatry; | 1995 |
Case study: behavioral symptoms of pediatric HIV-1 encephalopathy successfully treated with clonidine.
Topics: AIDS Dementia Complex; Attention Deficit Disorder with Hyperactivity; Child, Preschool; Clonidine; H | 1995 |
Adderall and other drugs for attention-deficit/hyperactivity disorder.
Topics: Amphetamines; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous | 1994 |
Alpha-2-adrenoceptor sensitivity in heroin addicts with and without previous attention deficit disorder/hyperactivity and conduct disorder.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; beta-Endorphin; Clonidine; Growth | 1994 |
Extended-release clonidine for sleep disorders.
Topics: Adolescent; Arousal; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Delayed-Action | 1994 |
Children who have attentional disorders: interventions.
Topics: Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; C | 1994 |
Attention deficit hyperactivity disorder in adults: diagnosis, treatment, and prognosis.
Topics: Adult; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Clonidine; D | 1994 |
Safety of clonidine and nortriptyline.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Drug Therapy, Combinati | 1994 |
Clonidine for stimulant-related sleep problems.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Dextroamphetamine; Drug Therapy, Co | 1994 |
Nortriptyline treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Comorbidity; Family Hea | 1993 |
Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome.
Topics: Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Clonidine; Desipramine; Female; Hum | 1993 |
Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Clonidine; Comor | 1993 |
Medication for children with attentional disorders. American Academy of Pediatrics Committee on Children With Disabilities and Committee on Drugs.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; | 1996 |
Attention-deficit disorder with hyperactivity.
Topics: Attention Deficit Disorder with Hyperactivity; Child, Preschool; Clonidine; Drug Overdose; Female; H | 1996 |
Clonidine: a practical guide for usage in children.
Topics: Administration, Cutaneous; Administration, Oral; Adrenergic alpha-Agonists; Attention Deficit Disord | 1996 |
Predictors of clonidine response in Tourette syndrome: implications and inferences.
Topics: Adolescent; Adrenergic alpha-Agonists; Age Factors; Attention Deficit Disorder with Hyperactivity; C | 1996 |
Attention deficit disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Comorbidity; Humans; Psychotropic D | 1996 |
Assessment and diagnosis of attention deficit/hyperactivity disorder in pediatric general practice.
Topics: Antidepressive Agents, Tricyclic; Antihypertensive Agents; Attention Deficit Disorder with Hyperacti | 1996 |
Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Clonidine; Dose- | 1996 |
Clonidine for treatment of attention-deficit/hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervous System; Ce | 1996 |
Case study: adverse response to clonidine.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Fatal Ou | 1997 |
Fragile X: treatment of hyperactivity.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; | 1997 |
Clonidine poisoning--an emerging problem: epidemiology, clinical features, management and preventative strategies.
Topics: Attention Deficit Disorder with Hyperactivity; Charcoal; Child; Child Behavior Disorders; Child, Pre | 1998 |
Clinical guidelines for hyperkinetic disorder. European Society for Child and Adolescent Psychiatry.
Topics: Adolescent; Adrenergic alpha-Agonists; Antidepressive Agents; Attention Deficit Disorder with Hypera | 1998 |
Case study: accidental clonidine patch overdose in attention-deficit/hyperactivity disorder patients.
Topics: Administration, Cutaneous; Adolescent; Adrenergic alpha-Agonists; Attention Deficit Disorder with Hy | 1999 |
Clonidine: adverse responses.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Child; Clo | 1998 |
Clonidine overdose in childhood: implications of increased prescribing.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Bradycardia; Child; Child, | 1998 |
Combining methylphenidate and clonidine: a clinically sound medication option.
Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Aggression; Antihypertensive Agents; Attention | 1999 |
Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment.
Topics: Adult; Ambulatory Care; Attention; Attention Deficit Disorder with Hyperactivity; Clonidine; Cogniti | 1999 |
Case series: clonidine has no systematic effects on PR or QTc intervals in children.
Topics: Adolescent; Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Central Nervou | 1999 |
Clonidine and methylphenidate.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; | 1999 |
Drugged-out toddlers. A new study documents an alarming increase in behavior-altering medication for preschoolers.
Topics: Age Factors; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous S | 2000 |
[Attention deficit disorder with hyperactivity in children: diagnosis and therapeutic management].
Topics: Adolescent; Adrenergic alpha-Agonists; Antidepressive Agents; Attention Deficit Disorder with Hypera | 2000 |
A 1000-fold overdose of clonidine caused by a compounding error in a 5-year-old child with attention-deficit/hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Antihypertensive Agents; Attention Deficit Disorder with Hyperactivity; C | 2001 |
[Functioning, comorbidity and treatment of 141 adults with attention deficit hyperactivity disorder (ADHD) at a psychiatric outpatient department].
Topics: Adrenergic alpha-Agonists; Adult; Age Factors; Attention Deficit Disorder with Hyperactivity; Centra | 2001 |
[Therapy of tic disorders apparently of organic origin in a multi-morbid 5-year-old patient with lofexidine (Britlofex) and clonidine (Catapressan)].
Topics: Affective Symptoms; Aggression; Attention Deficit Disorder with Hyperactivity; Brain Damage, Chronic | 2001 |
Trends and toxic effects from pediatric clonidine exposures.
Topics: Adolescent; Adrenergic alpha-Agonists; Age Distribution; Attention Deficit Disorder with Hyperactivi | 2002 |
Use of medication by young people with attention-deficit/hyperactivity disorder.
Topics: Adolescent; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Australia; Central | 2002 |
Clonidine in hyperkinetic children.
Topics: Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Dibenzothiepi | 1990 |
The clonidine patch and behavior problems.
Topics: Administration, Cutaneous; Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child B | 1990 |
[The treatment of children with Gilles de la Tourette's syndrome].
Topics: Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Haloperidol; | 1987 |
Parotid gland salivary secretion in Tourette's syndrome and attention deficit disorder: a model system for the study of neurochemical regulation.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Female; Humans; Male; P | 1987 |
Tourette's syndrome in Monroe County school children.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Behavior; Child; Child, Preschool; Clonid | 1988 |
Neuroendocrine aspects of attention deficit hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Growth Hormone; Humans; | 1988 |
Treatment effects of oral and transdermal clonidine in relation to methylphenidate: an open pilot study in ADD-H.
Topics: Administration, Cutaneous; Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Clonidi | 1987 |
Is clonidine a behavioural teratogen in the human?
Topics: Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Clonidine; Dose-Response Rel | 1986 |